Vaishali Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Vaishali Pharma Ltd · Outcome · 15 Nov 2026, 1:11 am
Vaishali Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 3,017 (-9.8% YoY | +31.8% QoQ) ■ EBITDA: 205 (+47.7% YoY | +38.2% QoQ) ■ EBITDA Margin (%): 6.8 (+265 bps YoY | +32 bps QoQ) ■ PAT: 206 (+73.6% YoY | +33.2% QoQ) ■ EPS (INR): 0.16 (+77.8% YoY | +33.3% QoQ)
Original exchange filing (PDF)
More announcements from Vaishali Pharma Ltd
- Vaishali Pharma Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 15 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 14 Nov 2026
- Vaishali Pharma Limited has informed the Exchange regarding Appointment of Mr. Rohil Sanjay Desai and Mr. Ketur Kishor Shah as Non- Executive Independent Director of the company w.e.f. November 05, 2026. · 06 Nov 2026
- Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026. · 06 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve Other business/Increase in authorised capital/Fund raising. · 03 Nov 2026
- To consider Fund Raising and other business matters · 03 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about General Updates · 17 Oct 2026
